These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25703229)

  • 1. Web resources for pharmacogenomics.
    Zhang G; Zhang Y; Ling Y; Jia J
    Genomics Proteomics Bioinformatics; 2015 Feb; 13(1):51-4. PubMed ID: 25703229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress towards the integration of pharmacogenomics in practice.
    Mooney SD
    Hum Genet; 2015 May; 134(5):459-65. PubMed ID: 25238897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics.
    Dalabira E; Viennas E; Daki E; Komianou A; Bartsakoulia M; Poulas K; Katsila T; Tzimas G; Patrinos GP
    Public Health Genomics; 2014; 17(5-6):265-71. PubMed ID: 25228099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice.
    Manolopoulos VG
    Clin Chem Lab Med; 2007; 45(7):801-14. PubMed ID: 17617019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A guide to the current Web-based resources in pharmacogenomics.
    Glubb DM; Paugh SW; van Schaik RH; Innocenti F
    Methods Mol Biol; 2013; 1015():293-310. PubMed ID: 23824864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the cost-effectiveness of pharmacogenomics.
    Veenstra DL; Higashi MK; Phillips KA
    AAPS PharmSci; 2000; 2(3):E29. PubMed ID: 11741245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Singapore Pharmacogenomics Portal: a web resource for evaluating human genetic variations of genes responsible for drug responses.
    Wong LP; Poh WT; Chan SL; Tan LL; Toh DS; Chia KS; Sung C; Teo YY
    Pharmacogenet Genomics; 2013 Jun; 23(6):329-32. PubMed ID: 23546522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DrugBank and its relevance to pharmacogenomics.
    Wishart DS
    Pharmacogenomics; 2008 Aug; 9(8):1155-62. PubMed ID: 18681788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Pharmacogenetics and Pharmacogenomics Research in Current Medical Practice.
    Prakash S; Agrawal S
    Curr Drug Metab; 2016; 17(9):862-876. PubMed ID: 27494310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Pharmacogenomics: Applications in Nephrology.
    Adams SM; Crisamore KR; Empey PE
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1561-1571. PubMed ID: 29793969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current pharmacogenomic approaches to clinical drug development.
    Murphy MP
    Pharmacogenomics; 2000 May; 1(2):115-23. PubMed ID: 11256585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 7: Pharmacogenomics.
    Karczewski KJ; Daneshjou R; Altman RB
    PLoS Comput Biol; 2012; 8(12):e1002817. PubMed ID: 23300409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory approval for new pharmacogenomic tests: a comparative overview.
    Joly Y; Koutrikas G; Tassé AM; Issa A; Carleton B; Hayden M; Rieder MJ; Ramos-Paque E; Avard D
    Food Drug Law J; 2011; 66(1):1-24, i. PubMed ID: 24505844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cost-effectiveness analysis in the era of pharmacogenomics.
    Flowers CR; Veenstra D
    Pharmacoeconomics; 2004; 22(8):481-93. PubMed ID: 15217305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PharmGKB: the Pharmacogenomics Knowledge Base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2013; 1015():311-20. PubMed ID: 23824865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems Pharmacogenomic Landscape of Drug Similarities from LINCS data: Drug Association Networks.
    Musa A; Tripathi S; Dehmer M; Yli-Harja O; Kauffman SA; Emmert-Streib F
    Sci Rep; 2019 May; 9(1):7849. PubMed ID: 31127155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics in dermatology: tools for understanding gene-drug associations.
    Daneshjou R; Huddart R; Klein TE; Altman RB
    Semin Cutan Med Surg; 2019 Mar; 38(1):E19-E24. PubMed ID: 31051019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics/updated for precision medicine in dermatology.
    Do LHD; Maibach H
    J Dermatolog Treat; 2019 Jun; 30(4):410-413. PubMed ID: 30238807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.